Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions
- 30 October 2014
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 74 (21) , 6036-6047
Abstract
Ex vivo–expanded CD8+ T cells used for adoptive immunotherapy generally acquire an effector memory-like phenotype (TEM cells). With regard to therapeutic applications, two undesired features of this phenotype in vivo are limited persistence and reduced antitumor efficacy, relative to CD8+ T cells with a central memory-like phenotype (TCM cells). Furthermore, there is incomplete knowledge about all the differences between TEM and TCM cells that may influence tumor treatment outcomes. Given that TCM cells survive relatively longer in oxidative tumor microenvironments, we investigated the hypothesis that TCM cells possess relatively greater antioxidative capacity than TEM cells. Here, we report that TCM cells exhibit a relative increase compared with TEM cells in the expression of cell surface thiols, a key target of cellular redox controls, along with other antioxidant molecules. Increased expression of redox regulators in TCM cells inversely correlated with the generation of reactive oxygen and nitrogen species, proliferative capacity, and glycolytic enzyme levels. Notably, T-cell receptor–transduced T cells pretreated with thiol donors, such as N-acetyl cysteine or rapamycin, upregulated thiol levels and antioxidant genes. A comparison of antitumor CD8+ T-cell populations on the basis of surface thiol expression showed that thiol-high cells persisted longer in vivo and exerted superior tumor control. Our results suggest that higher levels of reduced cell surface thiols are a key characteristic of T cells that can control tumor growth and that profiling this biomarker may have benefits to adoptive T-cell immunotherapy protocols. Cancer Res; 74(21); 6036–47. ©2014 AACR.Keywords
All Related Versions
This publication has 52 references indexed in Scilit:
- Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory DevelopmentImmunity, 2012
- TOR in the immune systemCurrent Opinion in Cell Biology, 2011
- A Central Role for mTOR Kinase in Homeostatic Proliferation Induced CD8+ T Cell Memory and Tumor ImmunityImmunity, 2011
- Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growthProceedings of the National Academy of Sciences, 2011
- Direct control of mitochondrial function by mTORProceedings of the National Academy of Sciences, 2009
- Diversity in T Cell Memory: An Embarrassment of RichesImmunity, 2009
- Predicting CD62L expression during the CD8+ T‐cell response in vivoImmunology & Cell Biology, 2009
- mTOR regulates memory CD8 T-cell differentiationNature, 2009
- T cell surface redox levels determine T cell reactivity and arthritis susceptibilityProceedings of the National Academy of Sciences, 2006
- Programming CD8+ T cells for effective immunotherapyCurrent Opinion in Immunology, 2006